Postnatal ovarian activation has effects in estrogen target tissues in infant girls

Tanja Kuiri-Hänninen1, Mikko Haanpää, Ursula Turpeinen

  • 1William Harvey Research Institute, Barts and the London, Queen Mary University of London, London EC1M 6BQ, United Kingdom. l.dunkel@qmul.ac.uk.

Insights

Postnatal ovarian activity, indicated by rising estradiol (E₂) levels, influences reproductive tissue development in infant girls. This suggests a crucial role for the pituitary-ovarian axis in early female reproductive maturation.

Area of Science:

  • Reproductive Endocrinology
  • Pediatric Endocrinology
  • Neonatal Development

Background:

  • Postnatal pituitary gonadotropin secretion is transiently activated in both sexes, more robustly in preterm (PT) infants.
  • While testicular activity is linked to this surge in boys, gonadal activation in infant girls remains poorly understood.

Purpose of the Study:

  • To evaluate the association between postnatal ovarian activity and estrogen target tissue changes in full-term (FT) and preterm (PT) infant girls.
  • To compare estrogen levels and target tissue responses between sexes to understand ovarian contribution.

Main Methods:

  • Urinary estradiol (E₂) levels were measured in FT and PT girls (n=29 and 34) from 1 week to 6 months using mass spectrometry.
  • E₂ levels in girls were compared with those in FT and PT boys (n=29 and 33).
  • E₂ levels were correlated with simultaneous changes in mammary glands, uterus, and vulvar epithelium.

Main Results:

  • Median urinary E₂ levels increased after day 7 in girls but not in boys.
  • Mammary gland diameter was larger in girls than boys from M2 (PT) and M4 (FT).
  • PT girls exhibited higher E₂ levels at term compared to FT girls, positively associated with mammary gland and uterine growth.

Conclusions:

  • Gonadal steroidogenesis activates in girls during the postnatal gonadotropin surge.
  • Elevated postnatal estradiol (E₂) levels impact estrogen target tissues in infant girls.
  • Postnatal pituitary-ovarian activation is integral to normal female reproductive development.
Abstract

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.5K
Oogenesis01:22

Oogenesis

Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
5.1K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
5.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.5K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K